UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P260 Improvement in treatment satisfaction among patients with PIDD on an investigational 20% subcutaneous immunoglobulin therapy

Annals of allergy, asthma, & immunology, 2016-11, Vol.117 (5), p.S99-S99

2016

Volltextzugriff (PDF)

Projecting Changes in total days of therapy (DOT) In Patients Hospitalized for Acute Bacterial Skin and Skin Structure Infection (Absssi)

Value in health, 2015-05, Vol.18 (3), p.A244-A244

2015

Volltextzugriff (PDF)

Cost Implications of Tedizolid use in acute Bacterial Skin and Skin Structure Infection (Absssi) for Hospitals and Managed care Organizations (Mcos)

Value in health, 2015-05, Vol.18 (3), p.A240-A240

2015

Volltextzugriff (PDF)

ME3 Censor Adjusted Net Monetary Benefit of Anti-HCV Therapy in the Variety of Real-World Treatment Setting

Value in health, 2012-11, Vol.15 (7), p.A605-A605

2012

Volltextzugriff (PDF)

Relationship Between Microbiological Eradication and Clinical Outcome with Antibiotic Treatment in Nosocomial Pneumonia, Complicated Urinary Tract Infection, and Complicated Intra-Abdominal Infection

Value in health, 2014-11, Vol.17 (7), p.A664-A664

2014

Volltextzugriff (PDF)

PSY18 A DECISION ANALYSIS MODEL EXPLORING THE RESULTS OF A PHASE II TRIAL OF ELTROMBOPAG FOR PATIENTS WITH CHRONIC HEPATITIS C, CIRRHOSIS AND THROMBOCYTOPENIA

Value in health, 2011, Vol.14 (3), p.A62-A62

2011

Volltextzugriff (PDF)

PND55 USE OF TIME-TO-EVENT ANALYSES TO DEFINE EPISODES OF CARE IN SICKLE CELL DISEASE

Value in health, 2011, Vol.14 (3), p.A212-A212

2011

Volltextzugriff (PDF)

PSY71 HEALTH AND FUNCTIONAL STATUS FOR INDIVIDUALS WITH THROMBOCYTOPENIA IN THE UNITED STATES: EVIDENCE FROM NHANES

Value in health, 2011, Vol.14 (3), p.A72-A72

2011

Volltextzugriff (PDF)

PSY70 ASSOCIATION OF PROVIDER CONTINUITY WITH HOSPITALIZATION AMONG FLORIDA MEDICAID ENROLLEES WITH SICKLE CELL DISEASE (SCD)

Value in health, 2011, Vol.14 (3), p.A71-A72

2011

Volltextzugriff (PDF)

PCV111 IDENTIFICATION OF RESPONSE SHIFT AMONG HYPERTENSIVE PATIENTS WITH CORONARY ARTERY DISEASE USING TWO STRUCTURAL EQUATION MODELING TECHNIQUES

Value in health, 2011, Vol.14 (3), p.A52-A53

2011

Volltextzugriff (PDF)

HPR1 Does Specialty Drug Coverage Vary between Health Plans' Medical and Pharmacy Benefit Policies?

Value in health, 2022-07, Vol.25 (7), p.S467

2022

Volltextzugriff (PDF)

PIN94 - Projecting Changes in total days of therapy (DOT) In Patients Hospitalized for Acute Bacterial Skin and Skin Structure Infection (Absssi)

Value in health, 2015-05, Vol.18 (3), p.A244-A244

2015

Volltextzugriff (PDF)

PIN74 - Cost Implications of Tedizolid use in acute Bacterial Skin and Skin Structure Infection (Absssi) for Hospitals and Managed care Organizations (Mcos)

Value in health, 2015-05, Vol.18 (3), p.A240-A240

2015

Volltextzugriff (PDF)

D22 NOSOCOMIAL AND FUNGAL INFECTIONS: Use Of Surveillance Data To Examine The Cost-Effectiveness Of Alternative Approaches To Empiric Antibiotic Therapy In Gram-Negative Nosocomial Pneumonia

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

PIN2 - Relationship Between Microbiological Eradication and Clinical Outcome with Antibiotic Treatment in Nosocomial Pneumonia, Complicated Urinary Tract Infection, and Complicated Intra-Abdominal Infection

Value in health, 2014-11, Vol.17 (7), p.A664-A664

2014

Volltextzugriff (PDF)

Systematic Review and Network Meta-Analysis of Tedizolid for the treatment of acute Bacterial Skin and Skin Structure Infection (Absssi) Due to Methicillin-Resistant Staphylococcus Aureus (Mrsa)

Value in health, 2015-05, Vol.18 (3), p.A231-A231

2015

Volltextzugriff (PDF)

PIN17 - Systematic Review and Network Meta-Analysis of Tedizolid for the treatment of acute Bacterial Skin and Skin Structure Infection (Absssi) Due to Methicillin-Resistant Staphylococcus Aureus (Mrsa)

Value in health, 2015-05, Vol.18 (3), p.A231-A231

2015

Volltextzugriff (PDF)

PGI24 A PILOT STUDY OF PATIENT PREFERENCES FOR MID-THERAPY ASSESSMENT TIMING IN CHRONIC HEPATITIS C TREATMENT

Value in health, 2010, Vol.13 (7), p.A373-A373

2010

Volltextzugriff (PDF)

The cost effectiveness of adherence

AIDS (London), 2000-10, Vol.14, p.S102-S102

2000

Volltextzugriff (PDF)

PAR16 CAN OSTEOARTHRITIS PATIENTS EVALUATE TRADEOFFS BETWEEN NSAID RISKS AND BENEFITS?

Value in health, 2006-05, Vol.9 (3), p.A29-A29

2006

Volltextzugriff (PDF)

MM4 Reconciling Decision Models with the Real World: The Cost-Effectiveness of Erythropoietin for Esrd-Related Anemia

Value in health, 1998-05, Vol.1 (1), p.85-86

1998

Volltextzugriff (PDF)

PAR14 CONTRIBUTION OF PAIN, SITE OF PAIN AND NUMBER OF JOINTS AFFECTED ON PRODUCTIVITY LOSS AMONG WORKERS AND NON-WORKERS WITH OSTEOARTHRITIS

Value in health, 2004-05, Vol.7 (3), p.244-244

2004

Volltextzugriff (PDF)

PMC47 WILLINGNESS TO INITIATE THERAPY AND PUBLIC HEALTH POLICY: AN APPLICATION TO THE STRATEGIC DEVELOPMENT OF CLINICAL PRACTICE GUIDELINES FOR HEPATITIS C TREATMENT

Value in health, 2009, Vol.12 (7), p.A395-A395

2009

Volltextzugriff (PDF)

PIH8 MEDICARE PART D AND STATE-LEVEL VARIATIONS IN MEDICARE ADVANTAGE PARTICIPATION

Value in health, 2007, Vol.10 (3), p.A157-A158

2007

Volltextzugriff (PDF)

PAR13 BURDEN OF OSTEOARTHRITIS AND ITS TREATMENT ON PATIENTS

Value in health, 2004-05, Vol.7 (3), p.244-244

2004

Volltextzugriff (PDF)

1 – 25 von 260

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(195)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

P260 Improvement in treatment satisfaction among patients with PIDD on an investigational 20% subcutaneous immunoglobulin therapy

Projecting Changes in total days of therapy (DOT) In Patients Hospitalized for Acute Bacterial Skin and Skin Structure Infection (Absssi)

Cost Implications of Tedizolid use in acute Bacterial Skin and Skin Structure Infection (Absssi) for Hospitals and Managed care Organizations (Mcos)

ME3 Censor Adjusted Net Monetary Benefit of Anti-HCV Therapy in the Variety of Real-World Treatment Setting

Relationship Between Microbiological Eradication and Clinical Outcome with Antibiotic Treatment in Nosocomial Pneumonia, Complicated Urinary Tract Infection, and Complicated Intra-Abdominal Infection

PSY18 A DECISION ANALYSIS MODEL EXPLORING THE RESULTS OF A PHASE II TRIAL OF ELTROMBOPAG FOR PATIENTS WITH CHRONIC HEPATITIS C, CIRRHOSIS AND THROMBOCYTOPENIA

PND55 USE OF TIME-TO-EVENT ANALYSES TO DEFINE EPISODES OF CARE IN SICKLE CELL DISEASE

PSY71 HEALTH AND FUNCTIONAL STATUS FOR INDIVIDUALS WITH THROMBOCYTOPENIA IN THE UNITED STATES: EVIDENCE FROM NHANES

PSY70 ASSOCIATION OF PROVIDER CONTINUITY WITH HOSPITALIZATION AMONG FLORIDA MEDICAID ENROLLEES WITH SICKLE CELL DISEASE (SCD)

PCV111 IDENTIFICATION OF RESPONSE SHIFT AMONG HYPERTENSIVE PATIENTS WITH CORONARY ARTERY DISEASE USING TWO STRUCTURAL EQUATION MODELING TECHNIQUES

HPR1 Does Specialty Drug Coverage Vary between Health Plans' Medical and Pharmacy Benefit Policies?

PIN94 - Projecting Changes in total days of therapy (DOT) In Patients Hospitalized for Acute Bacterial Skin and Skin Structure Infection (Absssi)

PIN74 - Cost Implications of Tedizolid use in acute Bacterial Skin and Skin Structure Infection (Absssi) for Hospitals and Managed care Organizations (Mcos)

D22 NOSOCOMIAL AND FUNGAL INFECTIONS: Use Of Surveillance Data To Examine The Cost-Effectiveness Of Alternative Approaches To Empiric Antibiotic Therapy In Gram-Negative Nosocomial Pneumonia

PIN2 - Relationship Between Microbiological Eradication and Clinical Outcome with Antibiotic Treatment in Nosocomial Pneumonia, Complicated Urinary Tract Infection, and Complicated Intra-Abdominal Infection

Systematic Review and Network Meta-Analysis of Tedizolid for the treatment of acute Bacterial Skin and Skin Structure Infection (Absssi) Due to Methicillin-Resistant Staphylococcus Aureus (Mrsa)

PIN17 - Systematic Review and Network Meta-Analysis of Tedizolid for the treatment of acute Bacterial Skin and Skin Structure Infection (Absssi) Due to Methicillin-Resistant Staphylococcus Aureus (Mrsa)

PGI24 A PILOT STUDY OF PATIENT PREFERENCES FOR MID-THERAPY ASSESSMENT TIMING IN CHRONIC HEPATITIS C TREATMENT

The cost effectiveness of adherence

PAR16 CAN OSTEOARTHRITIS PATIENTS EVALUATE TRADEOFFS BETWEEN NSAID RISKS AND BENEFITS?

MM4 Reconciling Decision Models with the Real World: The Cost-Effectiveness of Erythropoietin for Esrd-Related Anemia

PAR14 CONTRIBUTION OF PAIN, SITE OF PAIN AND NUMBER OF JOINTS AFFECTED ON PRODUCTIVITY LOSS AMONG WORKERS AND NON-WORKERS WITH OSTEOARTHRITIS

PMC47 WILLINGNESS TO INITIATE THERAPY AND PUBLIC HEALTH POLICY: AN APPLICATION TO THE STRATEGIC DEVELOPMENT OF CLINICAL PRACTICE GUIDELINES FOR HEPATITIS C TREATMENT

PIH8 MEDICARE PART D AND STATE-LEVEL VARIATIONS IN MEDICARE ADVANTAGE PARTICIPATION

PAR13 BURDEN OF OSTEOARTHRITIS AND ITS TREATMENT ON PATIENTS

Aktive Filter

Suchergebnisse filtern